Functional heterogeneity of non-small lung adenocarcinoma cell sub-populations

Cell Biology International

Volumn 36, Issue 1, 2012, Pages 99-103

  Bechyne, Iga ^a   Szpak, Katarzyna ^a   Madeja, Zbigniew ^a   Czyz, Jarosław ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Connexin 43 (Cx43); Invasion; Lung; Lung cancer; Metastability

Indexed keywords

CONNEXIN 43; NERVE CELL ADHESION MOLECULE;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL SUBPOPULATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MOLECULAR CLONING; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CONNEXIN 43; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MITOSIS; PHENOTYPE;

EID: 84858722519     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110151     Document Type: Article

References (25)

1. Bates DC, Sin WC, Aftab Q, Naus CC. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus. Glia 2007;55:1554-64.
2. Berx G, Raspe E, Christofori G, Thiery JP, Sleeman JP. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer Clin Exp Metastasis 2007;24:587-97.
3. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM et al. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 2008;25:629-42.
4. Croce MV, Colussi AG, Price MR, Segal-Eiras A. Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549). Pathol Oncol Res 1999;5:197-204.
5. Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M. Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 2009;11:323-38.
6. Czyz J. The stage-specific function of gap junctions during tumourigenesis. Cell Mol Biol Lett 2008;13:92-102.
7. Czyz J, Guan K, Zeng Q, Wobus AM. Loss of beta1 integrin function results in upregulation of connexin expression in embryonic stem cell-derived cardiomyocytes. Int J Dev Biol 2005;49:33-41.
8. Daniel-Wojcik A, Misztal K, Bechyne I, Sroka J, Miekus K, Madeja Z, Czyz J. Cell motility affects the intensity of gap junctional coupling in prostate carcinoma and melanoma cell populations. Int J Oncol 2008;33:309-15.
9. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 2007;448:901-7.
10. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Exp Med 2010;207:11-9.
11. Graf T, Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 2008;3:480-3.
12. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
13. Haass NK, Smalley KS, Herlyn M. The role of altered cell-cell communication in melanoma progression. J Mol Histol 2004;35:309-18.
14. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213:374-83.
15. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007;28:297-321.
16. Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, Nishimura T, Enomoto K. Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. J Membr Biol 2007;218:73-7.
17. Pollmann MA, Shao Q, Laird DW, Sandig M. Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 2005;7:R522-34.
18. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 2010;21(Suppl. 7):vii89-92.
19. Sottoriva A, Sloot PM, Medema JP, Vermeulen L. Exploring cancer stem cell niche directed tumor growth. Cell Cycle 2010a; 9:1472-9.
20. Sottoriva A, Verhoeff JJ, Borovski T, McWeeney SK, Naumov L, Medema JP et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res 2010b;70:46-56.
21. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
22. Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H et al. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. BMC Cancer 2010;10:414.
23. Visvader JE. Cells of origin in cancer. Nature 2011;469:314-22.
24. Watanabe N, Dickinson DA, Krzywanski DM, Iles KE, Zhang H, Venglarik CJ et al. A549 subclones demonstrate heterogeneity in toxicological sensitivity and antioxidant profile. Am J Physiol Lung Cell Mol Physiol 2002;283:L726-36.
25. Wysoczynski M, Miekus K, Jankowski K, Wanzeck J, Bertolone S, Janowska-Wieczorek A et al. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res 2007;67:2131-40.